---
tags:
  - iints/source
  - iints/source/trial
source_id: "nejm_2019_control_iq"
source_bucket: "packaged_evidence"
category: "trial"
component: "aid_benchmarking"
url: "https://doi.org/10.1056/NEJMoa1907863"
doi: "10.1056/NEJMoa1907863"
status: active
---

# Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

> [!info] What this source supports
> Reference envelope for realistic AID performance ranges in benchmark narratives.

| Field | Value |
| --- | --- |
| Source ID | `nejm_2019_control_iq` |
| Bucket | `packaged_evidence` |
| Category | `trial` |
| SDK component | `aid_benchmarking` |
| DOI | 10.1056/NEJMoa1907863 |
| URL | https://doi.org/10.1056/NEJMoa1907863 |
| Origin file | `src/iints/presets/evidence_sources.yaml` |

## Citation

Brown SA, et al. N Engl J Med. 2019;381(18):1707-1717.

## User Interpretation

Use this source to explain **why the SDK default, metric, dataset, or hardware-safety boundary exists**. It is evidence support for pre-clinical simulation and documentation, not a medical approval claim.
